Literature DB >> 22775139

Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Jung Hae Yoon1, Eric Johnson, Rui Xu, Laura T Martin, Paul T Martin, Federica Montanaro.   

Abstract

Dystroglycan is a major cell surface glycoprotein receptor for the extracellular matrix in skeletal muscle. Defects in dystroglycan glycosylation cause muscular dystrophy and alterations in dystroglycan glycosylation can impact extracellular matrix binding. Here we describe an immunoprecipitation technique that allows isolation of beta dystroglycan with members of the dystrophin-associated protein complex (DAPC) from detergent-solubilized skeletal muscle. Immunoprecipitation, coupled with shotgun proteomics, has allowed us to identify new dystroglycan-associated proteins and define changed associations that occur within the DAPC in dystrophic skeletal muscles. In addition, we describe changes that result from overexpression of Galgt2, a normally synaptic muscle glycosyltransferase that can modify alpha dystroglycan and inhibit the development of muscular dystrophy when it is overexpressed. These studies identify new dystroglycan-associated proteins that may participate in dystroglycan's roles, both positive and negative, in muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775139      PMCID: PMC3436944          DOI: 10.1021/pr300328r

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  58 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Comparative proteomic analysis of the insulin-induced L6 myotube secretome.

Authors:  Jong Hyuk Yoon; Kyungmoo Yea; Jaeyoon Kim; Yoon Sup Choi; Sehoon Park; Hyeongji Lee; Chang Sup Lee; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

3.  Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse.

Authors:  Caroline Lewis; Kay Ohlendieck
Journal:  Biochem Biophys Res Commun       Date:  2010-05-22       Impact factor: 3.575

Review 4.  Strategies for shotgun identification of integral membrane proteins by tandem mass spectrometry.

Authors:  Bingwen Lu; Daniel B McClatchy; Jin Young Kim; John R Yates
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

Review 5.  Function and genetics of dystrophin and dystrophin-related proteins in muscle.

Authors:  Derek J Blake; Andrew Weir; Sarah E Newey; Kay E Davies
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

6.  Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction.

Authors:  P T Martin; L J Scott; B E Porter; J R Sanes
Journal:  Mol Cell Neurosci       Date:  1999-02       Impact factor: 4.314

7.  Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.

Authors:  Holly H Nguyen; Vianney Jayasinha; Bing Xia; Kwame Hoyte; Paul T Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Differential association of syntrophin pairs with the dystrophin complex.

Authors:  M F Peters; M E Adams; S C Froehner
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

View more
  24 in total

1.  Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.

Authors:  Louis G Chicoine; Louise R Rodino-Klapac; Guohong Shao; Rui Xu; William G Bremer; Marybeth Camboni; Bethannie Golden; Chrystal L Montgomery; Kimberly Shontz; Kristin N Heller; Danielle A Griffin; Sarah Lewis; Brian D Coley; Christopher M Walker; K Reed Clark; Zarife Sahenk; Jerry R Mendell; Paul T Martin
Journal:  Mol Ther       Date:  2013-10-22       Impact factor: 11.454

2.  Spatial distribution and molecular dynamics of dystrophin glycoprotein components at the neuromuscular junction in vivo.

Authors:  Mohamed Aittaleb; Isabel Martinez-Pena Y Valenzuela; Mohammed Akaaboune
Journal:  J Cell Sci       Date:  2017-03-31       Impact factor: 5.285

3.  Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.

Authors:  Sandra Murphy; Heinrich Brinkmeier; Mirjam Krautwald; Michael Henry; Paula Meleady; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2017-08-12       Impact factor: 2.698

Review 4.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

5.  Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.

Authors:  Megan L Cramer; Guohong Shao; Louise R Rodino-Klapac; Louis G Chicoine; Paul T Martin
Journal:  Hum Gene Ther       Date:  2017-03-23       Impact factor: 5.695

6.  Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.

Authors:  Megan L Cramer; Rui Xu; Paul T Martin
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

7.  B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Authors:  Paul J Thomas; Rui Xu; Paul T Martin
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

Review 8.  AAV-based gene therapies for the muscular dystrophies.

Authors:  Julie M Crudele; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 9.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

Review 10.  The role of the dystrophin glycoprotein complex on the neuromuscular system.

Authors:  Dina C Belhasan; Mohammed Akaaboune
Journal:  Neurosci Lett       Date:  2020-02-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.